The 14-year incidence of visual loss in a diabetic population1☆,
Section snippets
Methods
Case identification methods and descriptions of the population have appeared in previous reports.7, 8, 9, 10, 11, 12 Briefly, the study area consisted of 11 counties in southern Wisconsin. From July 1, 1979 to June 30, 1980, 10,135 persons with diabetes were identified in the practices of 452 of 457 primary care physicians in the area. A two-part sample of 2990 of these persons was invited to participate in the baseline examination from 1980 to 1982. The first part consisted of the entire
Results
Of the 996 persons with younger onset diabetes who participated in the baseline examination, 891 (89.5%), 765 (76.8%), and 634 (63.7%) participated in the 4-, 10-, and 14-year examinations, respectively. Reasons for nonparticipation in the 4and 10-year examinations and characteristics of participants and nonparticipants have been described.8, 9
Of persons who participated in earlier examinations but who did not participate in the 14-year examination, 56 had died, 4 could not be located, 44
Discussion
There is a need for reliable estimates of vision loss due to diabetes. Such estimates are important for planning clinical trials by providing baseline levels for determining sample sizes, for planning public health programs to reduce the impact of diabetic complications, and for evaluating the results of the programs. It also is important that the estimates be representative of the general diabetic population. Many estimates are based on small sample sizes, limited follow-up, self-reports of
References (27)
- et al.
Visual impairment in diabetes
Ophthalmology
(1984) - et al.
The incidence of vision loss in a diabetic population
Ophthalmology
(1988) - et al.
Ten-year incidence of visual loss in a diabetic population
Ophthalmology
(1994) - et al.
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema
Ophthalmology
(1984) - et al.
Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies
J Clin Epidemiol
(1988) - et al.
Blindness in insulin-treated diabetic patients with age at onset <30 years
J Chronic Dis
(1987) Are there any glycemic thresholds for the serious microvascular diabetic complications?
J Diabetes Complications
(1995)Preliminary report on effects of photocoagulation therapy
Am J Ophthalmol
(1976)Photocoagulation for diabetic macular edemaEarly Treatment Diabetic Retinopathy Study report number 1
Arch Ophthalmol
(1985)The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
(1993)
How effective are treatments for diabetic retinopathy?
JAMA
Screening guidelines for diabetic retinopathy
Ann Intern Med
The National Eye Health Education Program: From Vision Research to Eye Health Education: Planning the Partnership
Cited by (423)
Endpoints for clinical trials in ophthalmology
2023, Progress in Retinal and Eye ResearchConvolution neural network model for predicting various lesion-based diseases in diabetic macula edema in optical coherence tomography images
2023, Biomedical Signal Processing and ControlDisparities in Vision Health and Eye Care
2022, OphthalmologyCitation Excerpt :As the prevalence of diabetes mellitus has increased in the United States, diabetic retinopathy (DR) has become the leading cause of legal blindness in persons aged 20 to 74.175 In addition to a diagnosis of type 1 or type 2 diabetes, there are several other diabetes-related risk factors for DR: higher hemoglobin A1c, insulin use, duration of disease, hypertension, and elevated blood glucose.176–178 Compared with White Americans, Black and Hispanic Americans tend to have a higher and more severe disease burden but lower rates of recommended screening and eye examinations.175,176,179,180
A Review on Diabetic Retinopathy
2024, Current Diabetes Reviews
- ☆
Supported by National Institutes of Health grant EYO 3083 (RK, BEKK) and, in part, by the Research to Prevent Blindness (RK, Senior Scientific Investigator Award).
- 1
The authors have no proprietary interests in any materials mentioned in this study.